Núria Amigó Grau
Degree in Physics and MSc in Biophysics from the Universitat de Barcelona. PhD in Biomedical Engineering from the Universitat Rovira i Virgili.
Biosfer Teslab was founded in 2013 as a spin-off of the Universitat Rovira i Virgili and the Institut de Recerca Biomèdica Catalunya Sud (IRB CatSud). We carry out nuclear magnetic resonance measurements, develop our own digital tools and analyse clinical and molecular data for four areas: research and clinical trials, clinical practice, health and longevity, and sport.
Biosfer Teslab was created to translate scientific knowledge into solutions that answer real biomedical questions. In our early years, we focused on nuclear magnetic resonance and advanced lipoprotein characterisation. From that base, the continuous development of new scientific and technological capabilities has turned us into a platform that brings together analytical technologies, bioinformatics, data analysis and our own digital tools. Today we support each project from the definition of the analytical strategy and the analysis of the sample to the interpretation of the results, their scientific publication and decision support.
Biosfer Teslab is founded to translate research in nuclear magnetic resonance into analytical services and in vitro diagnostic solutions for the study of metabolism.

The development of LipoScale® turns knowledge of lipoproteins into an advanced tool to characterise their lipid composition, particle number and size. It is Biosfer Teslab’s first major step in bringing an innovation born in research into scientific and clinical settings.
Discover LipoScale®NMR profiling extends its scope with glycoproteins, lipid families and low-molecular-weight metabolites, alongside increasingly integrated data analysis models. Biosfer Teslab thus evolves from an advanced test into a broader metabolomics platform.
See research servicesThe development of MetBalance® summarises metabolic status as a score and percentiles from the NMR profile. Metabolomics thus reaches health and longevity professionals as a tool to follow each person’s progress.
Discover MetBalance®Today we apply the same scientific basis in four settings: research and clinical trials, clinical practice, health and longevity, and sports performance. Each raises different questions and decisions; all share the same analytical rigour.
Explore the four areasA multidisciplinary team of PhDs, doctoral researchers and laboratory specialists, with backgrounds in physics, biochemistry, biotechnology, chemistry, bioinformatics, data science, engineering and quality management. As well as measuring and analysing, we interpret the results and publish them with research groups and clinical teams.
Degree in Physics and MSc in Biophysics from the Universitat de Barcelona. PhD in Biomedical Engineering from the Universitat Rovira i Virgili.
Degree in Computer Engineering and MSc in Computer Security and Intelligent Systems from the Universitat Rovira i Virgili.
Degree in Biotechnology, MSc in Nutrition and Metabolism, MSc in Integrated Quality, Environmental and Occupational Safety Management and PhD in Biochemistry from the Universitat Rovira i Virgili.
Agricultural engineer from the Universitat de Lleida and degree in Biotechnology from the Universitat Rovira i Virgili. MSc in Nutrition and Metabolism, MSc in Bioinformatics and PhD in Biochemistry from the Universitat Rovira i Virgili.
Degree in Chemistry, MSc in Occupational Risk Prevention and MSc in Nanoscience and Nanotechnology from the Universitat Rovira i Virgili. PhD in Chemistry from the Institut Català d’Investigació Química and the Universitat Rovira i Virgili.
Degree in Biomedical Engineering and Interuniversity MSc in Biomedical Data Science from the Universitat Rovira i Virgili.
Degree in Engineering Physics from the Universitat Politècnica de Catalunya, MSc in Materials Science from ETH Zürich and PhD in Materials Science and Engineering from the Universitat Politècnica de Catalunya.
Higher technician in Laboratory Analysis and Quality Control from the Institut Comte de Rius, with more than five years’ experience. Certified in process auditing under VDA 6.3:2023.
Degree in Molecular Biology from The University of Sheffield and MSc in Bioinformatics and Biostatistics from the Universitat Oberta de Catalunya. Industrial PhD candidate at Biosfer Teslab and the Universitat Rovira i Virgili.
Degree in Biomedical Engineering from the Universitat Rovira i Virgili and MSc in Artificial Intelligence from UNIR.
We take part in competitive, publicly funded R&D projects, work with a certified quality management system and, since 2013, scientific, business and international organisations have recognised our track record.
Development and validation of an innovative diagnostic solution for tuberculosis, based on identifying specific metabolomic biomarkers in urine samples using ¹H-NMR and advanced computational analysis and artificial intelligence tools.
Research and validation of an advanced screening tool for the early detection of preterm birth risk, combining metabolomics and electrohysterography.
Research and validation of an innovative colorectal cancer screening test based on nuclear magnetic resonance metabolomics, aimed at future implementation in clinical practice.
The Spanish Agency of Medicines and Medical Devices grants Biosfer Teslab a licence for software development.
Recognition of business activity based on innovation.
Quality management system certified by AENOR for in vitro diagnostic activities, biomedical research, laboratory services and medical software.
Medical device quality management system certified by AENOR to UNE-EN ISO 13485 for the design, development and production of in vitro diagnostic software.
Commitment to quality, safety, traceability, regulatory compliance and continuous improvement in in vitro diagnostics and biomedical research.
One of five Catalan start-ups that competed in the AI for Health session at MWC26 in Barcelona, with the lipoprotein profile to detect hidden cardiovascular risk.
Finalist in the elite sport innovation competition organised by FC Barcelona and Allianz.
Recognition for innovation and digitalisation, with the Spanish Chamber of Commerce and La Vanguardia.
Biosfer Teslab, among the local companies recognised for their commitment to innovation and digital transformation.
Núria Amigó, CEO of Biosfer Teslab, recognised in the scientific or technological development category.
Awarded by the foundation dedicated to industrial and intellectual property.
Selected for the accelerator programme for projects and start-ups with innovative technology-based solutions.
One of the awards for the talent of entrepreneurs and professionals in the Camp de Tarragona.
Selected for the international accelerator programme for high-impact start-ups.
Winner in the «Emprèn i Sorprèn» category.
Third prize, special mention, for the communication presented by Biosfer Teslab’s co-founders at the 27th SEA Congress.
Award for one of the two best business creation projects of the year in the Camp de Tarragona.
JCI Catalunya award for excellence in medical innovation.
The institutions Biosfer Teslab was born from, and the organisations and programmes that have supported specific projects.
University in the scientific ecosystem from which Biosfer Teslab was born.
Health research institute that connects Biosfer Teslab with biomedical and clinical research.
R&D programmes, international technological cooperation and Misión Salud projects.
Joint calls for research and innovation in health.
Funding for public–private collaboration projects.
Institutional framework for competitive research and innovation projects.
We share the results of our projects, the publications we take part in and the team’s activity, with a quarterly newsletter summarising each period.
A study involving Biosfer Teslab reveals markedly different cardiometabolic profiles in adolescents with anorexia nervosa, normal weight and obesity. Advanced lipoprotein profiling by nuclear magnetic resonance provides…
The menopausal transition involves hormonal, metabolic and vascular changes that may influence women’s cardiovascular health. Understanding these changes from an integrated perspective may open new opportunities for…
During the third quarter of 2026, Biosfer Teslab continued to make steady progress in research, innovation, and scientific collaboration. We strengthened our commitment to advancing precision medicine through the…
We are looking for curious, rigorous people who want to learn and contribute where the laboratory, data analysis and biomedical application meet, from internships to the PhD.
We consider proposals that fit our activity and the team’s capacity to supervise at any given time.
We value laboratory, bioinformatics, data analysis and complementary biomedical profiles.
If your experience could contribute to our projects, you can express your interest even if there is no vacancy advertised.
We do not need any sensitive documents at this first stage. If the proposal is a good fit, we will tell you how to proceed.
Tell us what you want to understand, develop or transform. We will define the most suitable approach with you.